These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37199642)

  • 1. Microbiological Epidemiology of Invasive Infections Due to Non-Beta-Hemolytic Streptococci, France, 2021.
    Plainvert C; Matuschek E; Dmytruk N; Gaillard M; Frigo A; Ballaa Y; Biesaga E; Kahlmeter G; Poyart C; Tazi A
    Microbiol Spectr; 2023 Jun; 11(3):e0016023. PubMed ID: 37199642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Species designation of streptococci causing infective endocarditis in patients with mitral valve prolapse.
    Quintero-Martinez JA; Hindy JR; Zein SE; Vikram HR; Bosch W; DeSimone DC; Baddour LM
    Int J Infect Dis; 2023 Jun; 131():71-74. PubMed ID: 36967036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early in vitro and in vivo development of high-level daptomycin resistance is common in mitis group Streptococci after exposure to daptomycin.
    García-de-la-Mària C; Pericas JM; Del Río A; Castañeda X; Vila-Farrés X; Armero Y; Espinal PA; Cervera C; Soy D; Falces C; Ninot S; Almela M; Mestres CA; Gatell JM; Vila J; Moreno A; Marco F; Miró JM;
    Antimicrob Agents Chemother; 2013 May; 57(5):2319-25. PubMed ID: 23478959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic impact of streptococcal and enterococcal bacteremia in hematology patients].
    Ombandza-Moussa E; Schlegel L; Vekhoff A; Gerbal R; Marie JP; Bouvet A
    Pathol Biol (Paris); 2002 Apr; 50(3):169-77. PubMed ID: 11980330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial activity of various antibiotics against oral streptococci isolated in the oral cavity.
    Pasquantonio G; Condò S; Cerroni L; Bikiqu L; Nicoletti M; Prenna M; Ripa S
    Int J Immunopathol Pharmacol; 2012; 25(3):805-9. PubMed ID: 23058035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-lactam antibiotics and viridans group streptococci.
    Lopardo HA; Vigliarolo L; Bonofiglio L; Gagetti P; García Gabarrot G; Kaufman S; Mollerach M; Toresani I; von Specht M
    Rev Argent Microbiol; 2022; 54(4):335-343. PubMed ID: 36266147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility of Viridians Group of Streptococci isolated from infective endocarditis patients from 2018 to 2023.
    Jagadeesan N; Karur K; Nandini MP; Manjunath CN; Prapulla Kumari N; Praveen Kumar HD
    Indian J Med Microbiol; 2024; 49():100576. PubMed ID: 38556250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tigecycline (GAR-936) activity against Streptococcus gallolyticus (bovis) and viridans group streptococci.
    Moet GJ; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3):333-6. PubMed ID: 16989974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
    Biedenbach DJ; Toleman MA; Walsh TR; Jones RN
    Diagn Microbiol Infect Dis; 2006 Jun; 55(2):119-27. PubMed ID: 16530373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum and resistance determinants of oral streptococci clinical isolates.
    Davidovich NV; Galieva AS; Davydova NG; Malygina OG; Kukalevskaya NN; Simonova GV; Bazhukova TA
    Klin Lab Diagn; 2020 Sep; 65(10):632-637. PubMed ID: 33245653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Analysis of Resistance Patterns of Oral Streptococci Obtained from Orofacial Infections Against Beta-lactams, Clindamycin and Vancomycin over 2014-2018.
    Leszczynski P; Sokol-Leszczynska B; Mlynarczyk A; Sawicka-Grzelak A; Mlynarczyk G
    Oral Health Prev Dent; 2019; 17(6):585-589. PubMed ID: 31508602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis.
    Teng LJ; Hsueh PR; Chen YC; Ho SW; Luh KT
    J Antimicrob Chemother; 1998 Jun; 41(6):621-7. PubMed ID: 9687100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs.
    Traub WH; Leonhard B
    Chemotherapy; 1997; 43(1):10-20. PubMed ID: 8996736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population structure and characterization of viridans group streptococci (VGS) isolated from the upper respiratory tract of patients in the community.
    Nakajima T; Nakanishi S; Mason C; Montgomery J; Leggett P; Matsuda M; Coulter WA; Millar BC; Goldsmith CE; Moore JE
    Ulster Med J; 2013 Sep; 82(3):164-8. PubMed ID: 24505152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viridans streptococcal (Streptococcus intermedius) mitral valve subacute bacterial endocarditis (SBE) in a patient with mitral valve prolapse after a dental procedure: the importance of antibiotic prophylaxis.
    Cunha BA; D'Elia AA; Pawar N; Schoch P
    Heart Lung; 2010; 39(1):64-72. PubMed ID: 20109987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF).
    Maeda Y; Elborn JS; Parkins MD; Reihill J; Goldsmith CE; Coulter WA; Mason C; Millar BC; Dooley JS; Lowery CJ; Ennis M; Rendall JC; Moore JE
    J Cyst Fibros; 2011 Mar; 10(2):133-9. PubMed ID: 21145793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External validation of the HANDOC score - high sensitivity to identify patients with non-beta-haemolytic streptococcal endocarditis.
    Sunnerhagen T; Højgaard Andersen M; Bruun NE; Bundgaard H; Iversen KK; Rasmussen M
    Infect Dis (Lond); 2020 Jan; 52(1):54-57. PubMed ID: 31621444
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of susceptibility to antibiotics of streptococci & enterococci isolated from patients with infective endocarditis on antibiotic treatment.
    Mihaila-Amrouche L; Schlegel L; Bouvet A;
    Indian J Med Res; 2004 May; 119 Suppl():80-3. PubMed ID: 15232168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of bacteremia caused by streptococci of the viridans group].
    Ruiz MP; Soriano F
    Enferm Infecc Microbiol Clin; 1994 Nov; 12(9):426-32. PubMed ID: 7811768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative activity and spectrum of broad-spectrum beta-lactams (cefepime, ceftazidime, ceftriaxone, piperacillin/tazobactam) tested against 12,295 staphylococci and streptococci: report from the SENTRY antimicrobial surveillance program (North America: 2001-2002).
    Fritsche TR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2003 Oct; 47(2):435-40. PubMed ID: 14522519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.